1. Impact of personalized diet and probiotic supplementation on inflammation, nutritional parameters and intestinal microbiota - The 'RISTOMED project': Randomized controlled trial in healthy older people
- Author
-
FISCHER, André, BLANC-BISSON, Christèle, DONINI, Lorenzo Maria, VALENTINI, Luzia, PINTO, Alessandro, BOURDEL-MARCHASSON, Isabelle, OSTAN, Rita, BRIGIDI, Patrizia, TURRONI, Silvia, HRELIA, Silvana, HRELIA, Patrizia, BERESWILL, Stefan, LEONCINI, Emanuela, MALAGUTI, Marco, ELE BLANC-BISSON, Christ, DURRIEU, Jessica, SPAZZAFUMO, Liana, BUCCOLINI, Fabio, PRYEN, Florence, DONINI, Lorenzo, FRANCESCHI, Claudio, LOCHS, Herbert, Valentini L, Pinto A, Bourdel-Marchasson I, Ostan R, Brigidi P, Turroni S, Hrelia S, Hrelia P, Bereswill S, Fischer A, Leoncini E, Malaguti M, Blanc-Bisson C, Durrieu J, Spazzafumo L, Buccolini F, Pryen F, Donini LM, Franceschi C, Lochs H., Università degli Studi di Roma 'La Sapienza' = Sapienza University [Rome], Centre de Gériatrie, CHU Bordeaux [Bordeaux]-Groupe Hospitalier Sud, Centre de résonance magnétique des systèmes biologiques (CRMSB), Centre National de la Recherche Scientifique (CNRS)-Université de Bordeaux (UB), Alma Mater Studiorum Università di Bologna [Bologna] (UNIBO), Université de Bordeaux (UB), Neuropathology Group, European Neuroscience Institute, University of Bologna, CIG - Interdepartmental Center 'L.Galvani', and Dept. of Gastroenterology, Hepatology and Endocrinology
- Subjects
Blood Glucose ,Male ,Homocysteine ,[SDV]Life Sciences [q-bio] ,030204 cardiovascular system & hematology ,Critical Care and Intensive Care Medicine ,Gastroenterology ,law.invention ,chemistry.chemical_compound ,Probiotic ,0302 clinical medicine ,Randomized controlled trial ,law ,Clinical endpoint ,Streptococcus thermophilus ,2. Zero hunger ,Aged, 80 and over ,0303 health sciences ,Lactobacillus delbrueckii ,Nutrition and Dietetics ,VSL#3 ,3. Good health ,Intestines ,Vitamin B 12 ,C-Reactive Protein ,Cholesterol ,Female ,medicine.symptom ,Inflammation Oxidative stress Aging VSL#3 Internet Nutritional software ,medicine.medical_specialty ,Subgroup analysis ,Inflammation ,03 medical and health sciences ,Folic Acid ,Internal medicine ,medicine ,Humans ,Vitamin B12 ,030304 developmental biology ,Aged ,Internet ,Biological Products ,business.industry ,Probiotics ,aging ,Feeding Behavior ,Diet ,Gastrointestinal Microbiome ,Lactobacillus ,Oxidative Stress ,chemistry ,Immunology ,Dietary Supplements ,Nutritional software ,Oxidative stre ,business ,[SDV.AEN]Life Sciences [q-bio]/Food and Nutrition ,Biomarkers ,Lactobacillus plantarum - Abstract
OBJECTIVES: To assess the impact of a personalized diet, with or without addition of VSL#3 preparation, on biomarkers of inflammation, nutrition, oxidative stress and intestinal microbiota in 62 healthy persons aged 65-85 years. DESIGN: Open label, randomized, multicenter study. PRIMARY ENDPOINT: High-sensitivity C-reactive protein. SETTING: Community. INTERVENTIONS: Eight week web-based dietary advice (RISTOMED platform) alone or with supplementation of VSL#3 (2 capsules per day). The RISTOMED diet was optimized to reduce inflammation and oxidative stress. MEASUREMENTS: Blood and stool samples were collected on days 1 and 56. RESULTS: Diet alone reduced ESR (p = 0.02), plasma levels of cholesterol (p < 0.01) and glucose (p = 0.03). Addition of VSL#3 reduced ESR (p = 0.05) and improved folate (p = 0.007), vitamin B12 (p = 0.001) and homocysteine (p < 0.001) plasma levels. Neither intervention demonstrated any further effects on inflammation. Subgroup analysis showed 40 participants without signs of low-grade inflammation (hsCRP
- Published
- 2014
- Full Text
- View/download PDF